Senvest Management LLC Cuts Stock Position in Axcelis Technologies, Inc. (NASDAQ:ACLS)

Senvest Management LLC cut its stake in shares of Axcelis Technologies, Inc. (NASDAQ:ACLS) by 3.6% in the third quarter, according to its most recent disclosure with the SEC. The firm owned 770,490 shares of the semiconductor company’s stock after selling 28,387 shares during the period. Axcelis Technologies comprises about 2.8% of Senvest Management LLC’s holdings, making the stock its 14th biggest holding. Senvest Management LLC’s holdings in Axcelis Technologies were worth $80,786,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in the stock. Signaturefd LLC raised its position in shares of Axcelis Technologies by 348.9% during the 2nd quarter. Signaturefd LLC now owns 211 shares of the semiconductor company’s stock worth $30,000 after purchasing an additional 164 shares during the last quarter. Blue Trust Inc. raised its holdings in shares of Axcelis Technologies by 223.8% during the second quarter. Blue Trust Inc. now owns 272 shares of the semiconductor company’s stock valued at $39,000 after acquiring an additional 188 shares during the last quarter. Ashton Thomas Private Wealth LLC purchased a new position in shares of Axcelis Technologies in the second quarter valued at approximately $39,000. Isthmus Partners LLC boosted its stake in shares of Axcelis Technologies by 87.3% in the second quarter. Isthmus Partners LLC now owns 33,270 shares of the semiconductor company’s stock worth $47,000 after acquiring an additional 15,507 shares during the last quarter. Finally, Meeder Asset Management Inc. purchased a new stake in shares of Axcelis Technologies during the second quarter worth approximately $69,000. 89.98% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

ACLS has been the topic of several recent research reports. B. Riley lowered their target price on shares of Axcelis Technologies from $190.00 to $165.00 and set a “buy” rating on the stock in a research note on Friday, August 2nd. Benchmark lowered shares of Axcelis Technologies from a “buy” rating to a “hold” rating in a research report on Friday, November 8th. Finally, Needham & Company LLC reiterated a “hold” rating on shares of Axcelis Technologies in a report on Friday, November 8th. Three research analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $167.33.

Axcelis Technologies Trading Up 2.4 %

Shares of ACLS opened at $75.07 on Friday. Axcelis Technologies, Inc. has a 12-month low of $69.35 and a 12-month high of $158.61. The firm has a market capitalization of $2.44 billion, a P/E ratio of 11.11, a P/E/G ratio of 2.28 and a beta of 1.60. The firm has a 50-day moving average price of $91.99 and a 200 day moving average price of $111.20. The company has a current ratio of 4.45, a quick ratio of 3.29 and a debt-to-equity ratio of 0.04.

Axcelis Technologies Profile

Axcelis Technologies, Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and Asia Pacific. The company offers high energy, high current, and medium current implanters for various application requirements.